UMIN ID: UMIN000015168
Registered date:16/09/2014
Investigation of optimal regimen of Fulvestrant in patients with postmenopausal ER-positive advanced recurrent breast cancer
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Patients with postmenopausal ER-positive advanced recurrent breast cancer |
Date of first enrollment | 2014/10/01 |
Target sample size | 1000 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Effects of clinical background and prior therapies on the treatment time with Fulvestrant (TTF) |
---|---|
Secondary Outcome | Secondary analysis 1.Effects of clinical background and prior therapies on overall survival (OS) after start of Fulvestrant 2.Descriptive statistics of treatment 3.Summary of therapies administered to subjects with long survival |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Female |
Include criteria | |
Exclude criteria | 1)Patients not agree with this study |
Related Information
Primary Sponsor | Japan Breast Cancer Research Group(JBCRG) |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | AstraZeneca K.K. |
Secondary ID(s) |
Contact
public contact | |
Name | Katsumasa Kuroi |
Address | 9-4-3F, Nihonbashikoamicho, Chuo-ku, Tokyo, Japan Japan 103-0016 |
Telephone | 03-6264-8873 |
office@jbcrg.jp | |
Affiliation | Japan Breast Cancer Research Group (JBCRG) Adminstrative office |
scientific contact | |
Name | 1)Hidetoshi 2)Shinji 1)Kawaguchi 2)Ohno |
Address | 1) 1 Bunkyo-cho , Matsuyama-shi, Ehime Japan Japan |
Telephone | 089-924-1111 |
hkawaguchi@matsuyama.jrc.or.jp | |
Affiliation | 1) Matsuyama Red Cross Hospital 2) The Cancer Institute Hospital Of JFCR 1) Department of breast surgery 2) Breast Oncology Center |